Glaukos (GKOS) Assets Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.79% |
| Dec 31, 2025 | -3.76% |
| Sep 30, 2025 | -0.30% |
| Jun 30, 2025 | -1.45% |
| Mar 31, 2025 | -2.80% |
| Dec 31, 2024 | -2.44% |
| Sep 30, 2024 | -4.51% |
| Jun 30, 2024 | -4.13% |
| Mar 31, 2024 | -3.00% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | -1.56% |
| Mar 31, 2023 | 7.65% |
| Dec 31, 2022 | 6.99% |
| Sep 30, 2022 | 48.58% |
| Jun 30, 2022 | 50.57% |
| Mar 31, 2022 | 66.47% |
| Dec 31, 2021 | 71.81% |
| Sep 30, 2021 | 77.43% |
| Jun 30, 2021 | 82.72% |
| Mar 31, 2021 | 84.31% |
| Dec 31, 2020 | 82.35% |
| Sep 30, 2020 | 86.78% |
| Mar 31, 2020 | 78.15% |
| Dec 31, 2019 | 82.62% |
| Sep 30, 2019 | 33.49% |
| Jun 30, 2019 | 34.52% |
| Mar 31, 2019 | 25.16% |
| Dec 31, 2018 | 21.06% |
| Sep 30, 2018 | 17.42% |
| Jun 30, 2018 | 10.11% |
| Dec 31, 2017 | 85.40% |